Want to see RLAY full AI Analyst Report?
Relay Therapeutics (RLAY) Ownership Overview
1.59% Insiders
11.21% Mutual Funds
60.01% Other Institutional Investors
14.59% ETFs
12.60% Public Companies and Individual Investors
The ownership structure of Relay Therapeutics (RLAY) stock is a mix of institutional, retail, and individual investors. Approximately 85.81% of the company’s stock is owned by Institutional Investors, 1.59% is owned by Insiders, and 12.60% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jul 30, 2026 | xxxxxxxxxxxxx | $27152 | |
Jul 30, 2026 | xxxxxxxxxxxxx | $13920 | |
Jul 30, 2026 | xxxxxxxxxxxxx | $41631 | |
Apr 30, 2026 | xxxxxxxxxxxxx | $14376 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2026 | xxxxxxxxxxxxx | $97023853 | |
Mar 31, 2026 | xxxxxxxxxxxxx | $6759453 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 14,106,187 | Institution | 6.44% | 292,562,318 | |
| 10,421,515 | Institution | 4.76% | 216,142,221 | |
| 8,253,402 | Institution | 3.77% | 171,175,557 | |
| 7,202,265 | Institution | 3.29% | 149,374,976 | |
| 7,076,302 | Institution | 3.23% | 146,762,503 | |
| 2,826,783 | Institution | 1.29% | 58,627,479 | |
| 1,793,207 | Institution | 0.82% | 37,191,113 | |
| 1,587,378 | Institution | 0.72% | 32,922,220 | |
| 1,532,860 | Institution | 0.70% | 31,791,516 | |
| 1,528,900 | Institution | 0.70% | 31,709,386 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,202,265 | Institution | 3.29% | 149,374,976 | |
| 1,793,207 | Institution | 0.82% | 37,191,113 | |
| 1,587,378 | Institution | 0.72% | 32,922,220 | |
| 1,528,900 | Institution | 0.70% | 31,709,386 | |
| 1,448,344 | Institution | 0.66% | 30,038,655 | |
| 1,447,360 | Institution | 0.66% | 30,018,246 | |
| 1,299,962 | Institution | 0.59% | 26,961,212 | |
| 943,720 | Institution | 0.43% | 19,572,753 | |
| 813,433 | Institution | 0.37% | 16,870,600 | |
| 683,671 | Institution | 0.31% | 14,179,337 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,825,932 | Institution | 3.11% | 128,532,300 | |
| 6,461,501 | Institution | 2.95% | 133,171,536 | |
| 4,167,470 | Institution | 1.90% | 86,433,328 | |
| 1,951,687 | Institution | 0.89% | 36,750,266 | |
| 1,218,605 | Institution | 0.56% | 25,273,868 | |
| 1,163,641 | Institution | 0.53% | 24,133,914 | |
| 907,089 | Institution | 0.41% | 17,080,486 | |
| 805,457 | Institution | 0.37% | 16,600,469 | |
| 592,247 | Institution | 0.27% | 12,206,211 | |
| 507,597 | Institution | 0.23% | 7,131,738 |
FAQ
Who Owns Relay Therapeutics Inc (RLAY)?
According to the latest TipRanks data, approximately 60.01% of the company's stock is held by institutional investors, 1.59% is held by insiders, and 12.60% is held by retail investors.
What percentage of Relay Therapeutics Inc (RLAY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 60.01% of Relay Therapeutics Inc (RLAY) stock is held by institutional investors.
What percentage of Relay Therapeutics Inc (RLAY) stock is held by retail investors?
According to the latest TipRanks data, approximately 12.60% of Relay Therapeutics Inc (RLAY) stock is held by retail investors.
Who owns the most shares of Relay Therapeutics Inc (RLAY)?
Joseph Edelman owns the most shares of Relay Therapeutics Inc (RLAY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.